Launch of Automated Redaction Tool, ReDak

Blog Image

Published on June 12, 2024

ZYLIQ AI-Innovation Announces the Launch of Automated Redaction Tool, ReDak.

Princeton, NJ - May 6, 2024/PRNewswire/ - ZYLIQ, a leading provider of AI/ML solutions for Medical Writing, is excited to announce the launch of its AI-driven Automated Redaction tool called ReDak.

In the Clinical Trial community, redacted documents are an essential requirement that is typically completed manually by subject matter experts. ZYLIQ has developed advanced technology to scan and comprehend entire documents, allowing for the seamless identification and redaction of both Personally Identifiable Information (PII) and Company Confidential Information (CCI). PII is redacted in blue, while CCI is redacted in black.

ReDak streamlines the redaction process by efficiently handling multiple documents, scanning them in order as they are uploaded. If the system can not predict CCI automatically, then the user can easily build a CCI list by identifying it once, allowing the application (and Machine Learning) to automatically learn and apply redactions throughout the entire document. The platorm allows users to select text to redact and add it to their PII/CCI library, and provides tools for redacting tables and figures.

Through a combination of closed-loop AI, sophisticated models, and algorithms, ReDak can accurately predict PII and CCI within documents to expedite the redaction process. As Machine Learning continues to enhance these algorithms, ReDak becomes more tailored to the user's specific company and more efficient with each use.

ReDak is offered as an annual software license with unlimited document uses, providing a cost-effective and reliable solution for redacting sensitive information in the Clinical Trial industry

About ZYLIQ:

ZYLIQ has been developed out of the decades of experience at the CRO, Symbiance. Ilango's unique experience with AI/ML (in financial services) and decades in LifeSciences helped create the atmosphere for AI-innovation for Medical Writing

ZYLIQ's Inventor/Product Manager, Farah Feroze explains, “Our philosophy is to create an effective automation tool for CSRs, instead of trying to apply AI to many different documents is paying off. We are proud to continue to develop new software tools from our CSR success.”

Press Contact:

Mark Pittman

M-Pittman@ZYLIQ.ai | 500 College Rd East,Ste 415,Princeton, NJ 08540, USA | info@ZYLIQ.ai | ZYLIQ.ai

Was this post helpful? Learn more about ZYLiQ Share article